e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Immunodepression and severe pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Endothelial dysfunction and prognostic significance of endothelin-1 in patients with severe pneumonia and pulmonary sepsis
Irina Balatskaya (Barnaul, Russian Federation), Tatiana Martynenko, Irina Balatskaya, Olga Dunaeva, Andrey Momot, Yakov Shoychet
Source:
International Congress 2015 – Immunodepression and severe pneumonia
Session:
Immunodepression and severe pneumonia
Session type:
Thematic Poster Session
Number:
2637
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Irina Balatskaya (Barnaul, Russian Federation), Tatiana Martynenko, Irina Balatskaya, Olga Dunaeva, Andrey Momot, Yakov Shoychet. Endothelial dysfunction and prognostic significance of endothelin-1 in patients with severe pneumonia and pulmonary sepsis. Eur Respir J 2015; 46: Suppl. 59, 2637
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
The role of procalcitonin (PCT) in differential diagnosis of pneumonia and pulmonary congestion associated with end-stage renal failure (ESRF)
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Usefulness of procalcitonin as a predictor for bacteremia and prognosis in severe sepsis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016
Endothelial dysfunction and its corrections in patients with severe community-aquired pneumonia (CAP)
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020
Cardiac autonomic alterations impact early and late outcomes in patients with community-acquired pneumonia
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
Community-acquired pneumonia with severe sepsis: Etiology and prognosis
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
CD4 as a predictor of systemic inflammatory response and death at severe community-acquired pneumonia
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Acute respiratory failure and severe sepsis may identify different clinical phenotypes in community-acquired pneumonia
Source: Annual Congress 2013 –Interesting research questions
Year: 2013
Procalcitonin as etiological marker of severe community-acquired pneumonia
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
E-selectin as a prognostic factor of patients who hospitalized for respiratory inflammation diseases; a single institutional study
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016
Pulmonary originated sepsis: Can N/L ratio be used as follow-up marker?
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016
Can procalcitonin or C-reactive protein predict supporative lung complications and ARDS at severe community-acquired pneumonia (CAP)?
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Risk factors for mortality in severe pneumonia patients followed in ICU
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015
Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012
Disseminated intravascular coagulation profiles in patients with septic shock on ECMO
Source: International Congress 2016 – Diagnostic and therapeutic challenges in acute respiratory failure
Year: 2016
Neutralizing the complement component C5a protects against lung injury and extrapulmonary organ injury in pneumococcal pneumonia induced sepsis
Source: International Congress 2014 – Critical illness and therapeutic interventions
Year: 2014
Left ventricular dysfunction in patients with COPD: Inflammation and endothelial dysfunction
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Accuracy of inflammatory markers to distinguish between pneumonia and pulmonary embolism in acute settings
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept